Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy
Status:
Recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
This is a pilot study designed to assess for relative change in cardiac 18F Florbetapir
uptake in patients with AL cardiac amyloidosis after appropriate chemotherapy.